Dysregulation of UBASH3B has been implicated in enhancing EGFR-mediated oncogenic signaling, suggesting a plausible role underlying the aggressive phenotype and poor clinical outcomes associated with HNSCC. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.